Bioptimus
PrivateLast Round
Series A
Jan 14, 2025
Total Funding Raised
$117M
Company Overview
Bioptimus is a biotechnology and artificial intelligence company that develops a universal AI foundation model to enhance scientific research and drive biotechnological innovation by transforming multiscale biological data into actionable insights.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Drug Discovery, ML Platforms, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Data as a Service
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioptimus Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Bioptimus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 14, 2025 | ||||
| Series A | Jan 14, 2025 | ||||
| Seed | Feb 20, 2024 |
Key People
Founding team and executive leadership
Bioptimus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boom Capital Ventures | Series A |
| Top Harvest Capital | Seed |
| HV Fund | Series A |
| NJF Capital | Seed |
| Andera Partners | Series A |
| Top Harvest Capital | Seed |
| Pomifer Capital Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 14, 2025
$41M round led by Cathay Innovation.
Bioptimus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioptimus's valuation, stock price, and market status.